<code id='AA57C95221'></code><style id='AA57C95221'></style>
    • <acronym id='AA57C95221'></acronym>
      <center id='AA57C95221'><center id='AA57C95221'><tfoot id='AA57C95221'></tfoot></center><abbr id='AA57C95221'><dir id='AA57C95221'><tfoot id='AA57C95221'></tfoot><noframes id='AA57C95221'>

    • <optgroup id='AA57C95221'><strike id='AA57C95221'><sup id='AA57C95221'></sup></strike><code id='AA57C95221'></code></optgroup>
        1. <b id='AA57C95221'><label id='AA57C95221'><select id='AA57C95221'><dt id='AA57C95221'><span id='AA57C95221'></span></dt></select></label></b><u id='AA57C95221'></u>
          <i id='AA57C95221'><strike id='AA57C95221'><tt id='AA57C95221'><pre id='AA57C95221'></pre></tt></strike></i>

          hotspot

          hotspot

          author:hotspot    Page View:16
          Trump Campaign Event In Nevada
          Ethan Miller/Getty Images

          WASHINGTON — Former President Trump is back to campaigning for tying Medicare drug prices to lower prices abroad.

          In Trump fashion, he claimed in a video announcement this month that he is the “only president in modern times” to take on the drug industry — and dinged President Biden directly.

          advertisement

          “Biden canceled my tough-on-pharma policies the moment he had a chance,” Trump said.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          focus

          23andMe had bad news about my health. I wish a person had delivered it
          23andMe had bad news about my health. I wish a person had delivered it

          ERICBARADAT/AFP/GettyImagesLastsummer,IthoughtitmightbefuntohavemyDNAanalyzed.Twocompanies,23andMean

          read more
          Readout Newsletter: Vertex, Pfizer, Kura, and other biotech news
          Readout Newsletter: Vertex, Pfizer, Kura, and other biotech news

          AdobeWanttostayontopofthescienceandpoliticsdrivingbiotechtoday? Signup togetourbiotechnewsletterinyo

          read more
          BioMarin wins approval for gene therapy to treat hemophilia A
          BioMarin wins approval for gene therapy to treat hemophilia A

          AdobeTheFoodandDrugAdministrationonThursdayapprovedagenetherapytotreatpeoplewithhemophiliaA,aninheri

          read more

          Biogen walks away from Aduhelm, years after polarizing approval

          JessicaRinaldi/TheBostonGlobeBiogenisgivingupitsownershipofAduhelm,theAlzheimer’sdiseasetreatmentwho